The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vaxart, Inc(NASDAQ:VXRT) 
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial...
Website: http://vaxart.com
Founded: 2004
Full Time Employees: 30
Sector: Healthcare
Industry: Biotechnology
Vaxart Days Payable Outstanding ttm (DPO)
Vaxart Days Receivable Outstanding ttm (DSO)
Vaxart Days Inventory Outstanding ttm (DIO)
Vaxart Op Cashflow Per Share ttm
Vaxart Free Cashflow Per Share ttm
Vaxart Cash Per Share ttm
Vaxart P/S ratio ttm
Vaxart (GAAP) P/E ratio ttm
Vaxart P/B ratio ttm
No extra charts and metrics for this ticker.